trial · primary record
LS301-IT 0.1 mg/kg
Non Small Cell Lung Cancer (NSCLC)
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 35 |
| Primary completion | 2027-09 |
| Primary endpoint | Clinically Significant Events |
| Registry ID | NCT07276789 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:35.571Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07276789
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.